Edgen Stock·Sep 23 2025, 05:42戻る
戻る
Boston Scientific Secures Expanded FDA Approval for FARAPULSE System, Bolstering Cardiology Portfolio
Edgen Stock·Sep 23 2025, 05:42
[1] Boston Scientific Corporation (BSX) Expands AI-Enhanced Heart Devices With FARAPULSE Approval[2] Boston Scientific's PFA system gets FDA approval for persistent AF By Investing.com[3] Boston Scientific's Q2 2025 Surge: A Blueprint for Sustained Outperformance in a Reshaped Medical Device Sector - AInvest